Your session is about to expire
← Back to Search
Povidone Iodine + Fluoride Varnish for Early Childhood Caries (PIES Trial)
PIES Trial Summary
This trial will compare the efficacy of 10% Polyvinylpyrrolidone-Iodine (PVPI) to prevent new cavitated caries lesions in children with Severe Early Childhood Caries (S-ECC), compared to the current standard of care (Placebo + Fluoride Varnish (FV)).
PIES Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPIES Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PIES Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My child has severe early tooth decay needing treatment in an OR, as defined by the AAPD.You have allergies to iodine, seafood, red or yellow food coloring, or tea. You also have a history of thyroid disease or are hypersensitive to fluoride varnish.I am between 2 and almost 6 years old, or I am the adult caregiver of someone in that age range.You cannot have taken any other experimental drugs within the month leading up to the study.
- Group 1: Povidone Iodine
- Group 2: Placebo
- Approved for 5 Other Conditions - This treatment demonstrated efficacy for 5 other conditions.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the participant count for this clinical investigation?
"Confirmed. Clinicaltrials.gov displays current information about this medical experiment, which was initially posted on September 15th 2022 and recently updated on the 19th of that same month. A total of 246 patients must be enrolled from a single site for the trial to proceed."
For whom is participation in this research project open?
"The medical trial is looking for 246 children aged between 2 and 6 years old that suffer from Severe-Early Childhood Caries (S-ECC). Eligibility criteria also extends to parent/primary caregivers who are 18 or older and in good health, with both parties agreeing to comply with study protocols. Additionally, participants must be ASA I or II according the American Society of Anesthesiologists classification system as well as adhere to all CDC, NYS Department of Health and URMC COVID-19 guidelines."
Are there still available positions in this scientific investigation?
"Affirmative. Clinicaltrials.gov reflects that this medical trial, which was initially advertised on September 15th 2022, is currently enrolling patients. A total of 246 individuals will be accepted from a single test centre."
Has the amalgamation of 10% povidone iodine and FV been granted sanction by the FDA?
"Our team at Power assessed 10% povidone iodine + FV to be a 2 on the safety scale due to existing data indicating protection from harm, but no evidence of efficacy."
Does this experiment accept individuals aged 25 and above as participants?
"This clinical trial is accepting patients aged between 24 and 71 months old."
Share this study with friends
Copy Link
Messenger